Anika Therapeutics (NSDQ:ANIK) said today that it won CE Mark approval in the European Union for its Orthovisc-T injection. The Bedford, Mass.-based company’s treatment is indicated to relieve pain and restore function in tendons affected by tennis elbow, or chronic lateral epicondylosis.
The sodium hyaluronate injection promotes tendon gliding and repair at the site of the damaged tissue, according to Anika.
Get the full story at our sister site, Drug Delivery Business News.
The post Anika Therapeutics wins CE Mark for tennis elbow injection appeared first on MassDevice.